In Episode 1 of the Hims House podcast, host Jonathan Stern, equity analyst Louis Stevens, and industry insider Dr. H discuss the unique aspects of Hims & Hers’ business model, focusing on its telemedicine approach and vertical integration. They explain how Hims bypasses traditional healthcare barriers by offering direct cash-based services, making healthcare more accessible. The conversation covers Hims’ ability to offer affordable, generic medications and its emphasis on personalized care as key differentiators. They also explore the company’s growth trajectory, particularly its rapid success with non-GLP-1 weight loss treatments, and consider both the bullish and bearish cases for Hims’ future in the evolving healthcare landscape. (00:00) - Introduction and Welcome to Hims House (01:30) - Hims Operating Outside Traditional Healthcare (04:01) - How Hims Bypasses Traditional Insurance (04:58) - Offering Drugs at a Fraction of the Cost (06:36) - The Moat of Hims (08:00) - Personalized Healthcare and Vertical Integration (14:36) - Weight Loss Category and Success Without GLP-1s (17:31) - Legacy Weight Loss Products vs GLP-1s (20:36) - Cost Differences Between Oral and Injectable Treatments (21:13) - Why Amazon Hasn’t Replicated Hims (23:52) - Emotional Connection in Healthcare (25:21) - Bear Case for Hims (28:24) - Bull Case and Final Thoughts